FDA

Gilead
Biotech

FDA slaps clinical hold on multiple Gilead HIV trials

Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid safety concerns.
Ben Adams Jun 10, 2025 10:48am
FDA

FDA clears Reflow Medical’s retrievable below-the-knee stent

Jun 9, 2025 11:00am
oncology cancer test mammogram mammography breast cancer

FDA clears Clairity's 5-year breast cancer risk prediction tool

Jun 5, 2025 1:00pm
FDA

Smiths Medical recalls infusion pumps over 3 safety risks

Jun 5, 2025 9:46am
embryonic stem cells

ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma

May 31, 2025 8:00am
rare diseases

Stealth CEO questions FDA rejection of rare disease drug

May 29, 2025 2:27pm